Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 2
1967 7
1968 3
1969 5
1970 8
1971 13
1972 24
1973 33
1974 34
1975 57
1976 56
1977 60
1978 64
1979 65
1980 82
1981 81
1982 88
1983 104
1984 99
1985 111
1986 108
1987 118
1988 127
1989 136
1990 171
1991 213
1992 165
1993 228
1994 268
1995 245
1996 261
1997 281
1998 286
1999 253
2000 312
2001 288
2002 304
2003 332
2004 323
2005 319
2006 364
2007 349
2008 317
2009 332
2010 336
2011 386
2012 411
2013 405
2014 418
2015 435
2016 383
2017 390
2018 383
2019 420
2020 345
2021 325
2022 196
2023 170
2024 72

Text availability

Article attribute

Article type

Publication date

Search Results

11,079 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Adult nodular lymphocyte predominant Hodgkin lymphoma"
Page 1
How I treat nodular lymphocyte-predominant Hodgkin lymphoma.
Eichenauer DA, Engert A. Eichenauer DA, et al. Blood. 2020 Dec 24;136(26):2987-2993. doi: 10.1182/blood.2019004044. Blood. 2020. PMID: 32877522 Free article. Review.
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity with distinct pathologic and clinical characteristics. Unlike the malignant cells in classical Hodgkin lymphoma, the disease-defining …
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity with distinct pa …
Hodgkin lymphoma: A 2020 update on diagnosis, risk-stratification, and management.
Ansell SM. Ansell SM. Am J Hematol. 2020 Aug;95(8):978-989. doi: 10.1002/ajh.25856. Epub 2020 Jun 8. Am J Hematol. 2020. PMID: 32384177 Free article.
DIAGNOSIS: Hodgkin lymphoma is composed of two distinct disease entities: classical HL and nodular lymphocyte predominant HL. Nodular sclerosis, mixed cellularity, lymphocyte depletion, and lymphocyte-rich HL are subg …
DIAGNOSIS: Hodgkin lymphoma is composed of two distinct disease entities: classical HL and nodular lymphocyte …
Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.
Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA. Fan Z, et al. Am J Surg Pathol. 2003 Oct;27(10):1346-56. doi: 10.1097/00000478-200310000-00007. Am J Surg Pathol. 2003. PMID: 14508396
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) has traditionally been recognized as having two morphologic patterns, nodular and diffuse, and the current WHO definition of NLPHL requires at least a partial nodular pattern. …
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) has traditionally been recognized as having two m …
Classic Hodgkin lymphoma in young people.
Gupta S, Craig JW. Gupta S, et al. Semin Diagn Pathol. 2023 Nov;40(6):379-391. doi: 10.1053/j.semdp.2023.06.005. Epub 2023 Jun 30. Semin Diagn Pathol. 2023. PMID: 37451943 Review.
Classic Hodgkin lymphoma (CHL) is a unique form of lymphoid cancer featuring a heterogeneous tumor microenvironment and a relative paucity of malignant Hodgkin and Reed-Sternberg (HRS) cells with characteristic phenotype. Younger individuals (children, adoles …
Classic Hodgkin lymphoma (CHL) is a unique form of lymphoid cancer featuring a heterogeneous tumor microenvironment and a rela …
Nodular lymphocyte-predominant Hodgkin lymphoma.
Savage KJ, Mottok A, Fanale M. Savage KJ, et al. Semin Hematol. 2016 Jul;53(3):190-202. doi: 10.1053/j.seminhematol.2016.05.009. Epub 2016 May 13. Semin Hematol. 2016. PMID: 27496311 Review.
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma with distinct clinicopathologic features. It is typified by the presence of lymphocyte predominant (LP) cells, which are CD …
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma …
Nodular lymphocyte-predominant Hodgkin's lymphoma.
Nogovà L, Diehl V, Engert A; German Hodgkin Study Group. Nogovà L, et al. Curr Hematol Malig Rep. 2006 Mar;1(1):60-5. doi: 10.1007/s11899-006-0019-2. Curr Hematol Malig Rep. 2006. PMID: 20425333 Review.
Lymphocyte-predominant Hodgkin's lymphoma (LPHL) differs in histologic and clinical presentation from classical Hodgkin's lymphoma (cHL). Treatment of LPHL patients using standard Hodgkin's lymphoma protocols leads to comple …
Lymphocyte-predominant Hodgkin's lymphoma (LPHL) differs in histologic and clinical presentation from classical …
AYA Considerations for Aggressive Lymphomas.
Llaurador G, Giulino-Roth L. Llaurador G, et al. Curr Hematol Malig Rep. 2021 Feb;16(1):61-71. doi: 10.1007/s11899-021-00607-7. Epub 2021 Mar 16. Curr Hematol Malig Rep. 2021. PMID: 33728589 Review.
PURPOSE OF REVIEW: Lymphoma is the one of the most common cancer diagnoses among adolescents and young adults (AYAs) aged 15-39. ...We will discuss the current knowledge about disease biology in AYAs, adult and pediatric treatment strategies, novel tar …
PURPOSE OF REVIEW: Lymphoma is the one of the most common cancer diagnoses among adolescents and young adults (AYAs) aged 15-3 …
Diagnosis and management of Hodgkin lymphoma in children, adolescents, and young adults.
Belsky JA, Hochberg J, Giulino-Roth L. Belsky JA, et al. Best Pract Res Clin Haematol. 2023 Mar;36(1):101445. doi: 10.1016/j.beha.2023.101445. Epub 2023 Feb 3. Best Pract Res Clin Haematol. 2023. PMID: 36907636 Review.
Advances in the management of Hodgkin lymphoma in children, adolescents and young adult have resulted in survival outcomes exceeding 90%. ...This has been accomplished through response-adapted treatment approaches and the incorporation of novel agents, many o …
Advances in the management of Hodgkin lymphoma in children, adolescents and young adult have resulted in survival outco …
Management of limited-stage Hodgkin lymphoma.
Al-Juhaishi T, Ahmed S. Al-Juhaishi T, et al. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):500-509. doi: 10.1182/hematology.2023000511. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066938 Free article.
Hodgkin lymphoma (HL) is a rare type of B-cell malignancy with bimodal age distribution targeting young adults and elderly. ...Outcomes are generally excellent with standard chemotherapy or combined modality therapy. Balancing efficacy and the risk of late ef …
Hodgkin lymphoma (HL) is a rare type of B-cell malignancy with bimodal age distribution targeting young adults and elde …
Hodgkin's lymphoma in adults.
Townsend W, Linch D. Townsend W, et al. Lancet. 2012 Sep 1;380(9844):836-47. doi: 10.1016/S0140-6736(12)60035-X. Epub 2012 Jul 25. Lancet. 2012. PMID: 22835602 Free article. Review.
Management of Hodgkin's lymphoma continues to develop. Outcomes for patients with favourable-risk, early-stage disease are excellent, and serial reductions in intensity of treatment have been made to retain the excellent prognosis while reducing the late effe …
Management of Hodgkin's lymphoma continues to develop. Outcomes for patients with favourable-risk, early-stage disease …
11,079 results
You have reached the last available page of results. Please see the User Guide for more information.